These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11458909)

  • 1. C reactive protein and acute phase of ischaemic stroke.
    Di Napoli M
    BMJ; 2001 Jun; 322(7302):1605-6. PubMed ID: 11458909
    [No Abstract]   [Full Text] [Related]  

  • 2. The prognostic value of C-reactive protein (CRP) levels in patients with acute ischaemic stroke.
    Hamidon BB; Sapiah S; Nawawi H; Raymond AA
    Med J Malaysia; 2004 Dec; 59(5):631-7. PubMed ID: 15889566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.
    Welsh P; Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ
    Cerebrovasc Dis; 2009; 27(3):247-53. PubMed ID: 19176958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
    Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
    Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of C-reactive protein on functional outcome in ischemic stroke patients.
    Ryu SR; Choi IS; Bian RX; Kim JH; Han JY; Lee SG
    Int J Neurosci; 2009; 119(3):336-44. PubMed ID: 19116840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker.
    Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD
    Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide-range C-reactive protein efficacy in acute ischemic stroke patients.
    Shenhar-Tsarfaty S; Ben Assayag E; Bova I; Vered Y; Berliner S; Rogowski O; Shapira I; Bornstein NM
    Acta Neurol Scand; 2006 Jul; 114(1):29-32. PubMed ID: 16774624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond cholesterol: a new clue to heart disease.
    Johns Hopkins Med Lett Health After 50; 2003 Mar; 15(1):4-5. PubMed ID: 12703447
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy.
    Chirinos JA; Zambrano JP; Chakko S; Schob A; Veerani A; Perez GO; Mendez AJ
    Am J Cardiol; 2005 Jan; 95(1):88-90. PubMed ID: 15619397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6: an early marker for outcome in acute ischemic stroke.
    Waje-Andreassen U; Kråkenes J; Ulvestad E; Thomassen L; Myhr KM; Aarseth J; Vedeler CA
    Acta Neurol Scand; 2005 Jun; 111(6):360-5. PubMed ID: 15876336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically elevated C-reactive protein and vascular disease.
    Morita H; Nagai R
    N Engl J Med; 2009 Feb; 360(9):934; author reply 934-5. PubMed ID: 19256031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indicators of plaque stability].
    Steen H; Giannitsis E; Katus HA
    Herz; 2002 Feb; 27(1):64-7. PubMed ID: 11951796
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of arteriosclerosis using high sensitive CRP in multiphasic screening].
    Tonari Y; Koyama T; Saitoh K
    Rinsho Byori; 2004 Aug; 52(8):637-41. PubMed ID: 15478618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and dangerous liaisons.
    Biasucci LM
    Eur Heart J; 2000 Oct; 21(19):1560-2. PubMed ID: 10988002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting?].
    García-Moll X
    Rev Esp Cardiol; 2005 Jun; 58(6):615-7. PubMed ID: 15970115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of C-reactive protein in stroke prevention: bright and dark sides of the moon.
    Di Napoli M; Papa F
    Expert Rev Neurother; 2004 Jul; 4(4):613-22. PubMed ID: 15853580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome].
    Sanchís J; Bodí V; Llácer A; Facila L; Martínez-Brotons A; Insa L; Chorro FJ
    Rev Esp Cardiol; 2004 May; 57(5):382-7. PubMed ID: 15151771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein is an indicator for fatal outcomes in first-time stroke patients.
    Koçer A; Canbulat C; Gözke E; Ilhan A
    Med Sci Monit; 2005 Nov; 11(11):CR540-4. PubMed ID: 16258400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.